Genetic testing and familial implications in breast-ovarian cancer families
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,General Biochemistry, Genetics and Molecular Biology
Reference65 articles.
1. Progress against cancer in the Netherlands since the late 1980: an epidemiological evaluation;Karim-Kos;Int J Cancer,2012
2. BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface;Lee;Br J Cancer,2014
3. Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of ‘easy to apply’ probability models;Bodmer;Br J Cancer,2006
4. Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing;Evans;J Med Genet,2009
5. Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study;Daniels;J Clin Oncol,2014
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Erfelijke kanker;Klachten na kanker;2024
2. La utilidad del análisis BRCA 1 y 2;Oncología Clínica;2022-11-08
3. Correlation between the number of false positive variants and the quality of results using Ion Torrent PGM™ sequencing to screen BRCA genes;Biomédica;2021-12-15
4. Oncologists’ perspectives of telephone genetic counseling to facilitate germline BRCA1/2 testing for their patients with high-grade serous ovarian cancer;Journal of Community Genetics;2021-05-06
5. Bright Pink Assess Your Risk™: a novel interactive tool for breast and ovarian cancer risk assessment (Preprint);Journal of Medical Internet Research;2021-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3